Paxman ABPXMBF 74 Interest Coverage is 0.58 as of Mar. 2026, which is 79% below its 10-year median of 2.71. GuruFocus rates PXMBF with a GF Score™ of 74/100 and a GF Value™ of $4.25. The stock has 3 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Paxman AB ranks worse than 213675% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Paxman AB's
Operating Income
for the
three
months ended in Mar. 2026 was $0.02 Mil. Paxman AB's Interest Expense for the
three
months ended in Mar. 2026 was $-0.03 Mil.
Paxman AB's interest coverage for the quarter that ended in Mar. 2026 was 0.58.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Paxman AB's Interest Coverage or its related term are showing as below:
PXMBF's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.71 * Ranked among companies with meaningful Interest Coverage only.
Paxman AB (OTCPK:PXMBF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Paxman AB Interest Coverage Related Terms
Paxman AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Paxman AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
PXMBF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Paxman AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Paxman AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paxman AB (PXMBF) has a Interest Coverage of 0.58 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Paxman AB and its competitors. This is 79% below median its historical median of 2.71. According to the industry distribution chart, Paxman AB ranks #999999 out of 468 companies in the Medical Devices & Instruments industry.
Is Paxman AB's Interest Coverage too high?
Paxman AB's current Interest Coverage of 0.58 is 79% below median its 10-year median of 2.71. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Paxman AB's value of 0.58 is 96.3% below this industry median. Based on the distribution chart, Paxman AB ranks #999999 out of 468 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Paxman AB has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #999999 out of 468 companies for Interest Coverage. This places Paxman AB in the lower half of its industry. The industry median Interest Coverage is 15.71. Paxman AB's value of 0.58 is 96.3% below this benchmark. While the company's 10-year median is 2.71 vs. the industry median of 15.71, Paxman AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paxman AB's current Interest Coverage of 0.58 is 96.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Paxman AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current Interest Coverage is 0.58, which is 79% below median its own 10-year median of 2.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Interest Coverage of 0.58. The stock's GF Value™ is $4.25, compared to a current price of $3.50 — trading 17.6% below its estimated fair value. The current Interest Coverage is 0.58, which is 79% below median its 10-year median of 2.71 and 96.3% below the Medical Devices & Instruments industry median of 15.71. Paxman AB's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Interest Coverage is 0.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 17.6% below its estimated GF Value™ of $4.25.
Key valuation signals for PXMBF:
Interest Coverage: 0.58 (79% below median its 10-year median of 2.71)
GF Value™: $4.25 vs. price of $3.50 (17.6% below fair value)
Industry Position: 96.3% below the Medical Devices & Instruments median (#999999 of 468)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
74GF Score
Get the complete analysis for PXMBF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
